on 12 Mar 2018
Last Applicant/ Owned by
MedReleaf Corp.
Suite 500, 10355 Jasper Ave.
Edmonton, , T5J 1Y6
Serial Number
UK00917873386 filed on 12th Mar 2018
Registration Number
UK00917873386 registered on
31st Jul 2018
Correspondent Information
Murgitroyd & Company
Murgitroyd House, 165-169 Scotland Street
Glasgow,
G5 8PL
Computer software, downloadable application software and computer application software accessible through a web operating system for use by healthcare providers to design and monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medication; computer software, downloadable application software and computer application software accessible through a web operating system to validate the safety and efficacy of medical cannabis as a therapeutic treatment for mental health and pain conditions; computer software, downloadable application software and computer application software accessible through a web operating system for generating clinical data respecting the safety, efficacy and patient compliance in the field of medical cannabis; computer software, downloadable application software and computer application software accessible through a web operating system to aid and improve on patient compliance of prescribed medications; computer software, downloadable application software and computer application software accessible through a web operating system to allow patients to track and log symptoms, side effects, dosage and administration information for prescription medication; computer software, downloadable application software and computer application software accessible through a web operating system for providing medical and scientific research information in the field of pharmaceuticals and clinical trials.
Administration of consumer loyalty programs.
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; software as a service (SAAS) services featuring software for use by healthcare providers to design and monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medication; software as a service (SAAS) services featuring software to validate the safety and efficacy of medical cannabis as a therapeutic treatment for mental health and pain conditions; software as a service (SAAS) services featuring software for generating clinical data respecting the safety, efficacy and patient compliance in the field of medical cannabis; software as a service (SAAS) services featuring software to aid and improve on patient compliance of prescribed medications; software as a service (SAAS) services featuring software to allow patients to track and log symptoms, side effects, dosage and administration information for prescription medication; maintenance and technical support services for computer software which allows patients to track and log symptoms, side effects, dosage and administration information for prescription medication, and enables healthcare providers to design and monitor pharmaceutical treatment plans, track patient compliance and verify treatment outcomes of prescription medication; maintenance and technical support services for computer software which provides medical and scientific research information in the field of pharmaceuticals and clinical trials.
UK00917873386
Word
Individual